Literature DB >> 22037570

Dispensable role for 4-1BB and 4-1BBL in development of vaccinia virus-specific CD8 T cells.

Yuan Zhao1, Michael Croft.   

Abstract

CD8 T cells are strongly induced in response to certain strains of vaccinia virus (VACV) and the generation of this population is tightly regulated by two Tumor Necrosis Factor (TNF)/TNFR superfamily members, OX40 (CD134) and CD27. In this study, we examined the role of another member of the TNFR superfamily, 4-1BB (CD137, TNFRSF9), and its ligand (4-1BBL, CD137L, TNFSF9), that have been described to control the generation of memory CD8 T cell populations elicited by other viruses such as influenza. Expression of 4-1BB and 4-1BBL was observed in wild-type mice during the primary infection, but we found that both 4-1BB and 4-1BBL deficient mice generated normal numbers of VACV-specific effector CD8 T cells that produced IFN-γ and TNF. Additionally, CD8 T cells deficient in 4-1BB were able to expand and persist comparably to wild-type T cells in response to VACV infection. Furthermore, the knockout mice also showed no defect in development of VACV-specific CD8 memory T cell populations. Lastly, showing alternate control mechanisms were not active in the gene-deficient environments that masked any activity, blocking 4-1BB/4-1BBL interactions using neutralizing antibody also had no effect on the number of VACV-specific memory CD8 T cells induced. Thus, our data demonstrate that 4-1BB and 4-1BBL do not play a strong or dominant role in driving the generation of high frequencies of VACV-specific CD8 T cells.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22037570      PMCID: PMC3243825          DOI: 10.1016/j.imlet.2011.10.008

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  35 in total

1.  Duration of antiviral immunity after smallpox vaccination.

Authors:  Erika Hammarlund; Matthew W Lewis; Scott G Hansen; Lisa I Strelow; Jay A Nelson; Gary J Sexton; Jon M Hanifin; Mark K Slifka
Journal:  Nat Med       Date:  2003-08-17       Impact factor: 53.440

2.  The 4-1BB costimulation augments the proliferation of CD4+CD25+ regulatory T cells.

Authors:  Guoxing Zheng; Bin Wang; Aoshuang Chen
Journal:  J Immunol       Date:  2004-08-15       Impact factor: 5.422

3.  Long-lived poxvirus immunity, robust CD4 help, and better persistence of CD4 than CD8 T cells.

Authors:  Rama Rao Amara; Pragati Nigam; Sunita Sharma; Jinyan Liu; Vanda Bostik
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

4.  Recombinant vaccinia virus-induced T-cell immunity: quantitation of the response to the virus vector and the foreign epitope.

Authors:  Laurie E Harrington; Robbert van der Most Rv; J Lindsay Whitton; Rafi Ahmed
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

5.  Temporal segregation of 4-1BB versus CD28-mediated costimulation: 4-1BB ligand influences T cell numbers late in the primary response and regulates the size of the T cell memory response following influenza infection.

Authors:  Edward M Bertram; Peggy Lau; Tania H Watts
Journal:  J Immunol       Date:  2002-04-15       Impact factor: 5.422

Review 6.  Co-stimulatory members of the TNFR family: keys to effective T-cell immunity?

Authors:  Michael Croft
Journal:  Nat Rev Immunol       Date:  2003-08       Impact factor: 53.106

7.  Blocking 4-1BB/4-1BB ligand interactions prevents herpetic stromal keratitis.

Authors:  Su K Seo; Hye Y Park; Jae H Choi; Won Y Kim; Young H Kim; Hyo W Jung; Byungsuk Kwon; Hyeon W Lee; Byoung S Kwon
Journal:  J Immunol       Date:  2003-07-15       Impact factor: 5.422

8.  Cutting edge: conventional CD8 alpha+ dendritic cells are generally involved in priming CTL immunity to viruses.

Authors:  Gabrielle T Belz; Christopher M Smith; Daniel Eichner; Ken Shortman; Guna Karupiah; Francis R Carbone; William R Heath
Journal:  J Immunol       Date:  2004-02-15       Impact factor: 5.422

9.  A switch in costimulation from CD28 to 4-1BB during primary versus secondary CD8 T cell response to influenza in vivo.

Authors:  Edward M Bertram; Wojciech Dawicki; Bradley Sedgmen; Jonathan L Bramson; David H Lynch; Tania H Watts
Journal:  J Immunol       Date:  2004-01-15       Impact factor: 5.422

10.  Cellular and humoral immunity against vaccinia virus infection of mice.

Authors:  Rong Xu; Aaron J Johnson; Denny Liggitt; Michael J Bevan
Journal:  J Immunol       Date:  2004-05-15       Impact factor: 5.422

View more
  10 in total

1.  The death receptor 3/TL1A pathway is essential for efficient development of antiviral CD4⁺ and CD8⁺ T-cell immunity.

Authors:  Jason P Twohig; Morgan Marsden; Simone M Cuff; John R Ferdinand; Awen M Gallimore; William V Perks; Aymen Al-Shamkhani; Ian R Humphreys; Eddie C Y Wang
Journal:  FASEB J       Date:  2012-05-16       Impact factor: 5.191

2.  Aging Converts Innate B1a Cells into Potent CD8+ T Cell Inducers.

Authors:  Catalina Lee-Chang; Monica Bodogai; Kanako Moritoh; Xin Chen; Robert Wersto; Ranjan Sen; Howard A Young; Michael Croft; Luigi Ferrucci; Arya Biragyn
Journal:  J Immunol       Date:  2016-03-16       Impact factor: 5.422

Review 3.  The TNF family in T cell differentiation and function--unanswered questions and future directions.

Authors:  Michael Croft
Journal:  Semin Immunol       Date:  2014-03-06       Impact factor: 11.130

4.  Commensal bacteria contribute to insulin resistance in aging by activating innate B1a cells.

Authors:  Monica Bodogai; Jennifer O'Connell; Ki Kim; Yoo Kim; Kanako Moritoh; Chen Chen; Fedor Gusev; Kelli Vaughan; Natalia Shulzhenko; Julie A Mattison; Catalina Lee-Chang; Weixuan Chen; Olga Carlson; Kevin G Becker; Manoj Gurung; Andrey Morgun; James White; Theresa Meade; Kathy Perdue; Matthias Mack; Luigi Ferrucci; Giorgio Trinchieri; Rafael de Cabo; Evgeny Rogaev; Josephine Egan; Jiejun Wu; Arya Biragyn
Journal:  Sci Transl Med       Date:  2018-11-14       Impact factor: 17.956

5.  Anatomically restricted synergistic antiviral activities of innate and adaptive immune cells in the skin.

Authors:  Heather D Hickman; Glennys V Reynoso; Barbara F Ngudiankama; Erica J Rubin; Javier G Magadán; Stephanie S Cush; James Gibbs; Barbara Molon; Vincenzo Bronte; Jack R Bennink; Jonathan W Yewdell
Journal:  Cell Host Microbe       Date:  2013-02-13       Impact factor: 21.023

6.  Accumulation of 4-1BBL+ B cells in the elderly induces the generation of granzyme-B+ CD8+ T cells with potential antitumor activity.

Authors:  Catalina Lee-Chang; Monica Bodogai; Kanako Moritoh; Purevdorj B Olkhanud; Andrew C Chan; Michael Croft; Julie A Mattison; Peter Johannes Holst; Ronald E Gress; Luigi Ferrucci; Fran Hakim; Arya Biragyn
Journal:  Blood       Date:  2014-07-18       Impact factor: 22.113

7.  Transcriptomic analysis of global changes in cytokine expression in mouse spleens following acute Toxoplasma gondii infection.

Authors:  Jun-Jun He; Jun Ma; Hui-Qun Song; Dong-Hui Zhou; Jin-Lei Wang; Si-Yang Huang; Xing-Quan Zhu
Journal:  Parasitol Res       Date:  2015-10-28       Impact factor: 2.289

8.  Targeting 4-1BB (CD137) to enhance CD8 T cell responses with poxviruses and viral antigens.

Authors:  Yuan Zhao; Vikas Tahiliani; Shahram Salek-Ardakani; Michael Croft
Journal:  Front Immunol       Date:  2012-11-08       Impact factor: 7.561

Review 9.  4-1BB Agonists: Multi-Potent Potentiators of Tumor Immunity.

Authors:  Todd Bartkowiak; Michael A Curran
Journal:  Front Oncol       Date:  2015-06-08       Impact factor: 6.244

10.  4-1BB signaling activates the t cell factor 1 effector/β-catenin pathway with delayed kinetics via ERK signaling and delayed PI3K/AKT activation to promote the proliferation of CD8+ T Cells.

Authors:  Do Y Lee; Beom K Choi; Don G Lee; Young H Kim; Chang H Kim; Seung J Lee; Byoung S Kwon
Journal:  PLoS One       Date:  2013-07-11       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.